Addison Advisors LLC Amgen Inc Transaction History

Addison Advisors LLC

$340 Million
Q3 2024

A detailed history of Addison Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Addison Advisors LLC holds 1,199 shares of AMGN stock, worth $353,141. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,199

Previous 1,195 0.33%

Holding current value

$353,141

Previous $373,000 3.49%

% of portfolio

0.11%

Previous 0.13%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$309.38 - $337.38 $1,237 - $1,349	4 Added 0.33%	1,199 $386,000
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $4,992 - $6,066	19 Added 1.62%	1,195 $373,000
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $168,506 - $190,095	659 Added 127.47%	1,176 $338,000
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $8,090 - $10,044	-37 Reduced 6.68%	517 $138,000
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $5,999 - $7,094	-28 Reduced 4.81%	554 $122,000
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $225 - $275	-1 Reduced 0.17%	582 $140,000
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $3,435 - $4,365	15 Added 2.64%	583 $153,000
Q3 2022 Oct 28, 2022	BUY	$224.46 - $253.15 $3,815 - $4,303	17 Added 3.09%	568 $128,000
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $4,614 - $5,134	20 Added 3.77%	551 $134,000
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $9,209 - $10,187	-42 Reduced 7.33%	531 $128,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $26,649 - $30,498	134 Added 30.52%	573 $129,000
Q3 2021 Nov 08, 2021	BUY	$212.27 - $248.7 $1,273 - $1,492	6 Added 1.39%	439 $93,000
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $93,692 - $111,571	433 New	433 $100,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Addison Advisors LLC with notifications on news.

Account

Addison Advisors LLC Amgen Inc Transaction History